Citadel Advisors’s Windtree Therapeutics Inc WINT Stock Holding History

Citadel Advisors’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-9,091	Closed	-$27K	–	8836
2015 Q4	$27K	Buy	+9,091	New	+$37.3K	﹤0.01%	7749
2015 Q3	–	Sell	-95	Closed	-$1K	–	9488
2015 Q2	$1K	Sell	95 -1,002	-91%	-$14.1K	﹤0.01%	8665
2015 Q1	$18K	Sell	1,097 -389	-26%	-$7.66K	﹤0.01%	7996
2014 Q4	$24K	Sell	1,486 -265	-15%	-$5.83K	﹤0.01%	7688
2014 Q3	$45K	Buy	1,751 +1,381	+373%	+$33.3K	﹤0.01%	6971
2014 Q2	$9K	Sell	370 -1,277	-78%	-$32.6K	﹤0.01%	7619
2014 Q1	$50K	Buy	1,647 +1,270	+337%	+$42.7K	﹤0.01%	6785
2013 Q4	$12K	Buy	+377	New	+$11.8K	﹤0.01%	6676

Other funds holding WINT

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Citadel Advisors's WINT Position: Q1 2016 in Review

Citadel Advisors sold out of Windtree Therapeutics Inc (WINT) in Q1 2016, closing a stake of 9,091 shares — an estimated $27K sold.

Citadel Advisors first reported a position in WINT in Q4 2013 and held it in 8 quarters. The position peaked at $50K in Q1 2014. 34 funds tracked by Wall St. Rank hold WINT as of Q1 2016.

Citadel Advisors reported no remaining Windtree Therapeutics Inc position as of Q1 2016 after selling out during the quarter.
Citadel Advisors sold 9,091 Windtree Therapeutics Inc shares in Q1 2016, an estimated $27K.
Citadel Advisors first reported a position in Windtree Therapeutics Inc in Q4 2013 and held it in 8 quarters.
Citadel Advisors's Windtree Therapeutics Inc position peaked at $50K in Q1 2014.
34 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2016.

Based on Citadel Advisors's 13F filing for Q1 2016, filed 13 May 2016.